IL27 and myeloid sarcoma: Investigators examined the expression patterns of IL-27 subunits in brain specimens from patients diagnosed with multiple sclerosis (MS) and compared them with control samples from neurologically healthy donors without any clinical or neuropathological signs of central nervous system disorders (34).